Metastatic progression, including extravasation and micrometastatic outgrowth, is the main cause of cancer patient death. Recent studies suggest that cancer cells reprogram their metabolism to support increased proliferation through increased glycolysis and biosynthetic activities, including lipogenesis pathways. However, metabolic changes during metastatic progression, including alterations in regulatory gene expression, remain undefined. We show that transforming growth factor beta 1 (TGFβ1)-induced epithelial-to-mesenchymal transition (EMT) is accompanied by coordinately reduced enzyme expression required to convert glucose into fatty acids, and concomitant enhanced respiration. Overexpressed Snail1, a transcription factor mediating TGFβ1-induced EMT, was sufficient to suppress carbohydrate-responsive-element-binding protein (ChREBP, a master lipogenic regulator), and fatty acid synthase (FASN), its effector lipogenic gene. Stable FASN knockdown was sufficient to induce EMT, stimulate migration and extravasation in vitro. FASN silencing enhanced lung metastasis and death in vivo. These data suggest that a metabolic transition that suppresses lipogenesis and favors energy production is an essential component of TGFβ1-induced EMT and metastasis.
INTRODUCTION
Metastatic disease is the primary cause of death in many cancers, especially in patients with breast and non-small cell lung (NSCLC) cancers. 1, 2 Tumor metastasis is a complex process, starting with primary tumor invasion through endothelial barriers by a process known as epithelial-to-mesenchymal transition (EMT), characterized by loss of cell-cell adhesion and increased cell motility. [3] [4] [5] Transforming growth factor beta 1 (TGFβ1) production within the tumor microenvironment is frequently enhanced in breast and NSCLCs. 6 Chronic TGFβ1 exposure stimulates cancer cell EMT, increasing cell motility and metastasis through its downstream signaling pathways, 7 including induction of several transcriptional factors, such as Snail1. 8, 9 In general, cancer cells maintain a high level of glycolysis in the presence or absence of oxygen (that is, the Warburg effect). Elevated glucose metabolism serves a variety of functions, including energy production, provision of macromolecular precursors and establishment of an NADPH pool to enable cells to resist oxidative stress. 10, 11 In addition to higher glycolytic rates, rapidly proliferating cancer cells commonly have substantial increases in de novo fatty acid synthesis for lipogenesis and membrane production. 12 Several lipogenic enzymes are required for cancer cell growth, including ATP citrate lyase, fatty acid synthase (FASN) and acetyl-CoA carboxylase (ACC). [13] [14] [15] [16] [17] Although glucose metabolism has been intensively investigated in rapidly growing cancer cells, metabolic changes that occur during EMT are poorly understood. Here, we demonstrate that transcriptional regulators of lipogenesis, carbohydrate-responsiveelement-binding protein (ChREBP) and sterol regulatory element-binding proteins (SREBP), are dramatically downregulated in A549 adenocarcinoma NSCLC cells during TGFβ1-induced EMT, a mechanism driven by increased SNAIL1 expression. Accordingly, cancer cells undergoing EMT have increased respiration, accompanied by elevated oxygen consumption and corresponding increases in ATP content. Importantly, Snail1 has a key role in regulating this metabolic reprogramming, as forced overexpression of Snail1 strongly suppressed ChREBP expression, a key lipogenic transcription factor. In turn, suppressed ChREBP levels reduced expression of FASN, an essential enzyme in de novo fatty acid synthesis, and enhanced EMT. Furthermore, stable FASN silencing by short-hairpin RNA knockdown was sufficient to enhance EMT, accompanied by prototypic changes in expression of the key functional mesenchymal marker genes, vimentin and E-cadherin, with stimulated cell migration in vitro. When examined in vivo, stable FASN knocked down cells showed enhanced metastatic potential and caused increased lethality due to metastatic spreading in nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice. Together, these data suggest that suppressing lipogenesis is an essential metabolic component of EMT and a requirement for successful establishment of distant metastases by diverting energy needed for cell migration and metastases.
RESULTS
Changes in metabolic enzyme expression during EMT Significant EMT was noted in A459 non-small cell lung carcinoma cells after low dose exposure to TGFβ1, as previously described.
Real-time PCR (RT-PCR) analysis using specific primers ( Supplementary Table S1) showed that E-cadherin, N-cadherin and Snail1 were regulated by TGFβ1 treatment, and all changes were blocked by addition of TGFβ1 type I kinase inhibitor (TGF inhibitor; Figure 1a ), strongly suggesting that the observed changes in EMT gene expression were specifically mediated by downstream TGFβ1 signaling. TGFβ1-induced EMT was further confirmed by increased cell motility in transwell assays (Figure 1b) .
Most cancer cells have high levels of glycolysis and fatty acid synthesis. 10 However, in cancer cells undergoing an EMT, cells become more mobile and may alter their overall metabolism. Indeed, the expression level of FASN was dramatically decreased during TGFβ1-induced EMT (Figure 1c) . Consistently, the fractional contribution of glucose to the fatty acid palmitate was reduced upon TGFβ1 treatment. This reduction was manifested in both the isotopomer distribution of palmitate and in the fraction of the lipogenic acetyl-CoA pool derived from [U- 13 C]glucose (Figure 1d ). Several transcription factors known to control lipogenesis, including PPARα, PPARγ, SREBP1 and SREBP2, were also downregulated in A549 NSCLC cells in response to TGFβ1 (Supplementary Figure 1) , with ChREBP demonstrating the most dramatic downregulation (Figure 1c ). All TGFβ1-induced metabolic changes were significantly suppressed by TGF inhibitor (HTS-466284) co-administration. Concomitantly, we noted dramatic increases in intracellular ATP content and oxygen consumption in TGFβ1-treated A549 NSCLC cells (Figure 1e ). The downregulation of lipogenesis was independent of TGFβ1-induced cell cycle arrest (Supplementary Figure 2) . TGFβ1-regulated lipogenic gene expression changes were also tested in mouse mammary epithelial cells (normal murine epithelial mammary gland; Supplementary Figure 3) , in which we previously demonstrated dramatic TGFβ1-induced EMT responses. TGFβ1-induced EMT in A549 cells is a reversible process, 20 whereby TGFβ1 withdrawal causes a mesenchymal-to-epithelial transition. Whereas decreases in E-cadherin, ACC and FASN were noted during TGFβ1 treatment with concomitant increases in N-cadherin and Snail1 protein levels, these responses were quickly reversed upon TGFβ1 withdrawal (Figures 2a and c) . Changes in FASN and ACC protein levels corresponded to the dramatic decrease and rebounding of ChREBP mRNA levels after TGFβ1 exposure and withdrawal (Figure 2b) , and mRNA levels of other lipogenic transcription factors also showed reversible expression ( Figure 2d ). Snail1-mediated metabolic regulation during EMT Snail1 is an important transcription factor that mediates the TGFβ1-induced EMT response. 8, 9 To explore the role of Snail1 in metabolic regulation stimulated by TGFβ1 exposure, Snail1 was 
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Similar to TGFβ1-induced EMT changes, Snail1-overexpressed cells expressed significantly lowered mRNA and protein levels of FASN and ACC (Figures 3a and e), which were not significantly affected by TGFβ1 treatments. Furthermore, ChREBP mRNA levels were also dramatically decreased in Snail1-overexpressed cells (Figure 3f ). Thus, overexpression of Snail1 closely mimicked metabolic regulation of lipogenic genes in TGFβ1-exposed A549 cells. As both FASN and ACC are known ChREBP target genes, 21 the metabolic regulatory role of Snail1 might be mediated by transcriptional control of ChREBP on FASN and ACC.
FASN silencing enhances metastatic capacity Fatty acid synthesis is required for rapidly proliferating cancer cells, and prior studies have shown that knockdown of FASN expression can impair cancer cell growth and overall survival. 22 To examine the roles of diminished FASN expression on cell motility, we transiently knocked down FASN using short interfering RNA transfection (siFASN) and noted significantly lower E-cadherin expression (Figure 4a ), which suggested an EMT and possibly increased mobility and metastatic capacity.
To further explore the functions of FASN expression on EMT and metastasis, stable FASN knocked down A549 cells were generated by lentiviral-mediated short-hairpin RNA infection using three separate FASN targeting oligomers. A pooled population of shFASN cells demonstrated enhanced mobility in transwell assays, which was further increased by TGFβ1 treatment (Supplementary Figure 5) . Three stable shFASN knocked down cell clones were separately isolated and each showed over 50% decreased FASN mRNA expression levels (Figure 4b ), similar to TGFβ1-exposed cells, with significantly suppressed FASN protein levels ( Figure 4c ). As expected, FASN silencing resulted in a reduced fractional contribution of glucose carbon to fatty acid synthesis (Figure 4d ). Compared with non-target controls, shFASN knocked down clones expressed significantly lower E-cadherin levels, with concomitantly higher N-cadherin and vimentin expression (Figure 4e ). All shFASN clones showed dramatically elevated mobility in transwell assays ( Figure 4f ).
As observed with TGFβ1-exposed cells, shFASN clones exhibited significant gradient increases in intracellular ATP pools correlating with the extent of FASN level knockdown. Consistently, FASN knockdown clones also had higher oxygen consumption rates (OCRs; Figure 4g ).
shFASN knockdown enhances A549 NSCLC cell lung colonization and lethality in NOD/SCID mice in vivo Next, we investigated the role of FASN loss in metastasis and lethality in NOD/SCID mice in vivo. Stable shNT and shFASN1 cells, which had slower growth rates and showed enhanced mobility in vitro (Figure 5a ), were injected into the tail veins of female NOD/SCID mice. Initially, deposition of cells into the lungs was not different between the two cell injections as measured 4 h post injection (Figure 5b ). Whereas many of the initially deposited NSCLC (Figure 5d ). Mice injected with shFASN cells also displayed significantly decreased overall survival than animals injected with shNT A549 cells (Figure 5e ). Autopsies of animals with initial lung cancers derived from shNT or shFASN only showed lung cancer colonization within the first 200 days. In contrast, mice that eventually died from injected shFASN cells not only demonstrated larger tumor volumes, with increased involvement of the overall lung, and decreased survival, but also dramatically increased metastatic spread to various other tissues, including adjacent lymph nodes, colon, liver and thymus (Table 1 ). In contrast, NOD/SCID mice that died from control or shNT A549 cells showed cancer involvement only in their lungs, with no effective spreading to adjacent lymph nodes or other tissues at the time of killing because of large tumor volumes (Supplementary Figure 6) .
DISCUSSION
Although cancer cells have higher glycolytic rates than normal cells, mitochondria of cancer cells are usually fully functional. 23, 24 During TGFβ1-induced EMT, increased oxygen consumption strongly suggests that mitochondrial oxidative phosphorylation is stimulated to generate ATP. A recent study showed that reduced migration is associated with reduced OXPHOS and ATP levels in viable cancer cells. 25 Increased de novo fatty acid synthesis is a general metabolic feature of cancer cells. 26 Prior studies suggested that enzymes in this pathway might be potential targets for cancer therapy, as genetic knockdown or chemical inhibition of these enzymes decreased cancer cell proliferation in vitro and subcutaneous xenograft tumor growth in vivo. [13] [14] [15] [16] [17] In response to TGFβ1, we discovered that ACC and FASN were coordinately decreased in A549 NSCLC cells, through a Snail1-mediated transcriptional regulatory network. Our data strongly suggest that Snail1 controls metabolic reprogramming of cancer cells in response to TGFβ1 by regulating several key metabolic transcriptional factors, including SREBP and ChREBP. 21, 27 Here, we discovered that ChREBP was dramatically downregulated by TGFβ1 in A549 cells, and forced overexpression of Snail1 mimicked this response. From promoter analyses, we identified three potential Snail1-binding sites (CACCTG at − 130, − 682 and − 1295 bp from the transcription start site) in the human ChREBP promoter that were identical to those in the human E-cadherin promoter, suggesting that Snail1 could directly bind to the ChREBP promoter and negatively regulate its expression, which will be further investigated by chromatin immunoprecipitation assay.
TGFβ1 exposure stimulates cell migration, a process requiring a rebalancing of energy from fatty acid synthesis to EMT promotion. As Snail1-forced overexpression simulated the same responses, this essential transcription factor appears important for both the morphological, as well as the metabolic, reprogramming that occurs during EMT. Indeed, methods to target Snail would be a potentially important means to inhibit cancer progression at both the levels of metabolic and morphologic reprogramming.
Our observation that decreased fatty acid synthesis regulates and ultimately stimulates cell migration and metastases raises considerable caution in targeting FASN or lipogenesis to prevent cancer. FASN knockdown A549 cells grew slower than control shNT A549 cells, consistent with prior results, 22 where the authors concluded that targeting these pathways could be an effective anticancer strategy. However, our results indicate that cells with decreased FASN also showed enhanced metastatic potential, similar to TGFβ1-exposed cells. Thus, while targeting FASN or lipogenesis in general may suppress growth of primary tumors, a major consequence is enhanced metastasis in NOD/SCID mice injected with shFASN A549 cells to mimic extravasation and cancer progression. One possibility is that loss of FASN expression increases the availability of substrates to carry out oxidative phosphorylation. The resulting shift from anabolism to energy production may help to support migration and ultimately metastasis. 28 These results strongly suggest that TGFβ1, elevated in many cancer microenvironments, 29 represents a new paradigm in cancer metabolic reprogramming, central for EMT-derived cell migration and metastases. TGFβ1 exposure shifts metabolism from fatty acid synthesis to enhanced oxidative phosphorylation, which generates sufficient ATP needed for cell migration and metastasis. Data suggest that targeting FASN or other lipogenic enzymes in cancer, while potentially eliciting temporary growth inhibition, might have the unanticipated detrimental consequence of increasing long-term risk of metastasis.
MATERIALS AND METHODS Reagents
Recombinant Human TGFβ1 was purchased from R&D systems (Minneapolis, MN, USA). The TGFβ1 type I kinase inhibitor (TGF inhibitor, HTS-466284) was purchased from Calbiochem (Darmstadt, Germany).
Cell lines A549 NSCLC cells were purchased from the American Type Culture Collection. Normal murine epithelial mammary gland cells were kindly provided by Dr Gray Pearson (UT Southwestern) and grown and used for EMT analyses as described. 19 All cells were MAP-tested and were free of mycoplasma contamination.
Stable Snail1-overexpressing A549 cells were generated using retroviralmediated pBABE-Snail1 expression vectors kindly provided by Dr Sendurai A Mani (University of Texas, MD Anderson Cancer Center, Houston, TX, USA). A pooled cell population was used for experiments after puromycin selection. Stable A549 non-targeted (shNT) and FASN knockdown (shFASN) cells were generated by lentiviral-mediated expression of three separate targeting short-hairpin RNAs for the FASN gene, and stable clones were isolated. The shFASN1 clone was selected for the in vivo study.
Palmitate de novo synthesis assay using [U- 13 C]glucose
In brief, cells were cultured in medium containing [U-
13
C]glucose for 24 h. The cells were harvested with 0.4 ml 0.1% Triton-X 100, followed by methanol : chloroform extraction. The chloroform phase was dried down with nitrogen gas resuspended with a 2-ml methanol : toluene (4:1 V/V) mixture containing 0.01% butylated hydroxytoluene and 2 μl acetyl chloride, and heated to 100°C for 1 h to generate methyl esters of palmitate and other fatty acids. After cooling down the sample, 5 ml of 6% K 2 CO 3 was added. The samples were centrifuged to separate the phases, and the upper toluene phase was transferred to a Gas Chromatography/ Mass Spectrometry (GC/MS) vial. Metabolites were analyzed using an Agilent 6970 (Santa Clara, CA, USA) gas chromatograph networked to an Agilent 5973 mass selective detector. Retention times and mass fragmentation signatures of methylpalmitate were validated using a pure standard. The mass isotopomer distribution analysis measured the fraction of each metabolite pool that contained every possible numbers of 13C atoms; that is, a metabolite could contain 0, 1, 2, … n 13 C atoms, where n = the number of carbons in the metabolite. For each metabolite, an informative fragment ion containing all carbons in the parent molecule was analyzed using the MSDChem software (Agilent), integrating the abundance of all mass isotopomers from m+0 to m+n, where m = the mass of the fragment ion without any 13 C. For palmitate, m = 270 and n = 16. The abundance of each mass isotopomer was then corrected mathematically to account for natural abundance isotopes and finally converted into a percentage of the total pool. Glucose-contributed lipogenic acetyl-CoA was calculated from the enrichment data by regression mathematical model.
OCR analyses
OCRs were measured using the XF24 Analyzer (Seahorse Bioscience, North Billerica, MA, USA) as described. 30 OCRs were normalized by cell number and data presented as relative X-fold changes versus control cells.
Intracellular ATP measurements
Intracellular ATP levels were measured using the Cell Titer-Glo Luminescent Cell Viability Assays (Promega, Madison, WI, USA). ATP concentrations were normalized by cell number and data expressed as relative X-fold changes versus untreated control cells.
Transwell migration assays
Log-phase Snail1 overexpressing, shFASN knockdown or appropriate control (vector alone or shNT) A549 cells (2X10 4 ) were pretreated with TGFβ1 for 24 h, with or without TGF inhibitor (400 nM, 1 h) and seeded into matrigel pre-coated transwell chambers in 0.1% fetal bovine serum DMEM. Cells migrating through membranes and attaching to the bottom of the transwell plates were counted after 48 h using BLI. Po 0.001.
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Wound-healing assay in vitro
Stable vector control and Snail1-overexpressing A549 cells were treated with TGFβ1, with or without TGF inhibitor (added 1 h before TGFβ1) and assessed for wound healing as described. 19 Relative X-fold changes compared with untreated or vector alone control cells were measured.
Cell cycle analyses A549 cells were treated with or without TGFβ1 for 48 h. Trypsinized cells were stained with propidium iodide and analyzed for cell cycle distribution using flow cytometry as described. 31 Ionizing radiation A549 cells were exposed to 2.5, 5.0 or 7.5 Gy of ionizing radiation using an X-RAD 320 irradiator from Precision X-Ray Inc (North Branford, CT, USA), cultured for 24 h under normal growth conditions, and then harvested for western blot analyses of cell cycle markers and metabolic enzymes.
Metastatic analyses
Female NOD/SCID mice (10 animals per group, 6-8 weeks old, 18-20 g) were tail-vein-injected with log-phase luciferase-labeled shFASN or shNT A549 cells (1X10 6 ) and imaged 4 h (to assess initial cells lodged into the lungs) and at various times (days) post injection. BLI measurements, animal weights and survival were measured over time. Mice were killed when weights decreased 10% because of tumor formation. The killed mice were assessed for metastatic spread to the lymph nodes, and other normal tissues by BLI signals ex vivo, and confirmed for tumor tissue using hematoxylin and eosine staining as described. 32 Immunohistochemistry Normal (n = 2 per group) tissues were processed, paraffin-embedded, sectioned (3 µm) and stained with hematoxylin and eosine to confirm tumor versus normal tissue as described. 19 
Immunoblot analyses
Protein extraction and immunoblot analyses were performed as described. 33 Primary antibodies used in this study were FASN, ACC, E-cadherin, Vimentin, Snail1 (Cell Signaling Technology, Beverley, CA, USA), N-cadherin, p53, p21 (Santa Cruz Biotechnology, Dallas, TX, USA), a-Tubulin, Actin (Sigma-Aldrich, St Louis, MO, USA) and GAPDH (Calbiochem).
Statistical analyses
All experiments were performed at least two times in duplicate, with many experiments performed three times in triplicate. Data in vitro were analyzed by two-tailed Student's t-tests. Tumor volumes, monitored by BLI, and survival (Kaplan-Meier) curves were statistically analyzed by analysis of variance. Data are represented as mean ± s.e.m.
